Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
cipla
10 Tablets in Strip
Letrozole
Keep in cold place
Delivering To:
Overview
Fempro Tablet aids in the treatment of postmenopausal women's breast cancer. It can be used alone or in combination with other therapies like radiation or surgery. Patients with advanced breast cancer might use the hormone treatment medication. Fempro 2.5 mg tablets are used to prevent the tumor from spreading to other body areas. The drug is an aromatase inhibitor and is marketed under the generic name letrozole.
Breast Cancer
Breast cancer
Most side effects of the Fempro 2.5 mg tablet do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Headaches
Heartburn
Muscle or joint pain
Vaginal bleeding
Shortness of breath
Yellowing of skin or eyes
Nausea
Vomiting
Fempro 2.5 mg tablets are a prescription-based medication that is taken orally with or without a meal as advised by the doctor. In case of an overdose of Fempro tablets, contact your doctor or any healthcare provider and seek medical attention immediately.
The CYP19A1 enzyme is blocked by the non-steroidal competitive aromatase inhibitor Fempro. As a result, the production of estrogen from androgens is stopped. The cancers that rely on estrogen, a natural female hormone, decrease in number as its levels decline. Some breast tumors that require estrogen to grow are less likely to spread when taken with these medications.
Alcohol
unsafe
It is advisable not to consume alcohol while taking medicine.
Pregnancy
consult your doctor
Do not take Fempro 2.5 mg tablet without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not take Fempro 2.5 mg tablet without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
If you forget to take a dose of Fempro 2.5 mg tablet consult your doctor. Don’t double up the next dose to cope with the missed one unless your doctor recommends it.
Fempro tablet is an anticancer tablet that is used for the treatment of breast cancer.
The tablet is taken orally once every day.
It is advisable to store the Fempro tablets at a place below 30°C.
The doctor decides for how long the treatment with Fempro 2.5 mg will continue depending on the condition, stage, and health of the patient.
Fempro can harm the foetus hence it is advisable to avoid pregnancy while using the tablets.
Yes. Some people may have headaches from the Fempro 2.5mg Tablet. If you have a headache, take it easy and rest. Consume a lot of liquids, including electrolytes or water. If necessary, apply a balm that relieves pain to the head. If your headache gets worse, see a doctor.
The Fempro 2.5mg Tablet can harm your immune system and reduce the quantity of white blood cells in your body. You might therefore be more susceptible to infection when using the Fempro 2.5mg Tablet. Your doctor will routinely check your blood counts as a precaution to prevent this. However, if you have any infection-related symptoms, such a fever, let your doctor know.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Fjermeros, K., Ghannoum, S., Geisler, S. B., Bhargava, S., Tahiri, A., Klajic, J., Geisler, J. (2024). The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer. Future Oncology, 20(32), 2457–2466.
Konstantinopoulos, P. A., et al. (2025). Treatment of recurrent endometrial cancer with metformin, letrozole, and abemaciclib is safe and promising. Presented at the Society of Gynecologic Oncology Annual Meeting, Seattle.
Lin, J., Wu, F., Wang, B., et al. (2024). Impact of letrozole co‑treatment in an antagonist protocol for IVF/ICSI: A retrospective study. Reproductive Biology and Endocrinology, 22, 126.
Mirza, M. R., Bjørge, L., Marmé, F., et al. (2025). Palbociclib plus letrozole in estrogen receptor‑positive advanced/recurrent endometrial cancer: double‑blind placebo‑controlled randomized phase II ENGOT‑EN3/PALEO trial. Gynecologic Oncology, 192, 128–136.
Xie, Y., Li, P., Hao, G. et al. (2025). Letrozole ovulation Regimen for frozen-thawed embryo transfer in women with polycystic ovary syndrome: a multi-centre randomised controlled trial. Reprod Biol Endocrinol 23, 103.
cipla
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.